Shell Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Shell Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,404	Closed	-$444K	–	1323
2023 Q4	$444K	Buy	+1,404	New	+$273K	0.02%	560
2020 Q4	–	Sell	-845	Closed	-$65K	–	1458
2020 Q3	$65K	Hold	845	–	–	﹤0.01%	1237
2020 Q2	$94K	Buy	+845	New	+$73.5K	﹤0.01%	1162

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Shell Asset Management's KRTX Position: Q1 2024 in Review

Shell Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,404 shares — an estimated $444K sold.

Shell Asset Management first reported a position in KRTX in Q2 2020 and held it in 3 quarters. The position peaked at $444K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Shell Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Shell Asset Management sold 1,404 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $444K.
Shell Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
Shell Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $444K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Shell Asset Management's 13F filing for Q1 2024, filed 14 May 2024.